Fri, August 16, 2024
Thu, August 15, 2024
Wed, August 14, 2024

Peter Lawson Maintained (SNDX) at Buy with Increased Target to $33 on, Aug 15th, 2024


//stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-33-on-aug-15th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Peter Lawson of Barclays, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Buy with Increased Target from $32 to $33 on, Aug 15th, 2024.

Peter has made no other calls on SNDX in the last 4 months.



There are 4 other peers that have a rating on SNDX. Out of the 4 peers that are also analyzing SNDX, 0 agree with Peter's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Peter


  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $33 on, Tuesday, August 6th, 2024
  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $37 on, Friday, June 28th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $42 on, Wednesday, June 26th, 2024
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $30 on, Thursday, May 9th, 2024

Publication Contributing Sources